Assessment of health problem status. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: betea glucan bread (control group)
3g/day. Intervention 2: betaglucan bread containing synbiotic (fructo oligosacaride and bacillus coagulance)
bciluse coagullance :18cfu/gram
fructo
Treatment - Drugs
betea glucan bread (control group)
3g/day
betaglucan bread containing synbiotic (fructo oligosacaride and bacillus coagulance)
bciluse coagullance :18cfu/gram
fructo oligo saccaride:10gram/day
betaglucan based bread containing synbiotic +acid lactic
betaglucan based bread containing lactic asid
lactic acid :4.4gram per kilogram of bread
Sponsors
Iran University of Medical Sciences, Occupational Health Research Center
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: inclusion criteria:age20-60years;lack of insulin consuming;FBS more than or equal to 126 mg/dl;glycosylated hemoglubin more than 6.5 percent;no consumption of any drug except drugs for control of blood glucose;no gestational diabetes;willingness to cooperate. exclusion criteria:history of metabolic diseases,cardiovascular disease,renal disease,tyroid ,cancer ;treatment with blood lipid affecting medications in the process of intervention;infectious diseases;gluten sensitive;smoking.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood sugar. Timepoint: before and after the intervention. Method of measurement: autoanalyzer.;Triglyceride. Timepoint: before and after the intervention. Method of measurement: autoanalyzer.;Low density lipopritein. Timepoint: before and after the intervention. Method of measurement: autoanalyzer.;High density lipoprotein. Timepoint: before and after the intervention. Method of measurement: autoanalyzer.;Insulin. Timepoint: before and after the intervention. Method of measurement: radioimmunoassay.;ApoA1. Timepoint: before and after the intervention. Method of measurement: immunotorbidometri.;ApoB100. Timepoint: before and after the intervention. Method of measurement: immunotorbidometri.;ALT. Timepoint: before and after the intervention. Method of measurement: spectrophotometri.;AST. Timepoint: before and after the intervention. Method of measurement: spectrophotometri.;ALP. Timepoint: before and after the intervention. Method of measurement: spectrophotometri.;TAC. Timepoint: before and after the intervention. Method of measurement: FRAP.;Superoxide dismutase. Timepoint: before and after the intervention. Method of measurement: FRAP.;Glutation peroxidase. Timepoint: before and after the intervention. Method of measurement: FRAP.;A1c glycosilated hemoglubin. Timepoint: before and after the intervention. Method of measurement: brinnate affinity.;Total cholestrol. Timepoint: before and after the intervention. Method of measurement: autoanalyzer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dietary intake. Timepoint: before intervention, 2 month after intervention. Method of measurement: questionnaire.;Weight. Timepoint: before and after the intervention. Method of measurement: digital balance.;Body mass index. Timepoint: before and after the intervention. Method of measurement: weight divides on the square of the height.;Physical activity. Timepoint: before and after the intervention. Method of measurement: international physical activity questionarre.;Blood pressure. Timepoint: before and after the intervention. Method of measurement: digital barometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzad Shidfar
Iran University of Medical Scinces
Outcome results
None listed